Vaccination in the elderly: What can be recommended?

Pierre Olivier Lang, Richard Aspinall

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The age-associated increased susceptibility to infectious disease would suggest that vaccination should be a route to promote healthy aging and keep our seniors autonomous and independent. While vaccination represents a cost-effective and efficient strategy at community level, the ability of the immune system to mount a protective immune response is still unpredictable at the level of the individual. Thus, at a similar age, some individuals, including the elderly, might still be 'good' responders while some other, even younger, would definitely fail to mount a protective response. In this review, the current burden of vaccine-preventable diseases in the aging and aged population will be detailed with the aim to identify the ideal vaccine candidates over the age of 50 years. This article will conclude with potential strategies to reduce, as best as possible, this burden and the imperative need to overcome barriers in extending current vaccine coverage towards to a lifelong vaccine schedule.

Original languageEnglish
Pages (from-to)581-599
Number of pages19
JournalDrugs and Aging
Volume31
Issue number8
Early online date14 Jun 2014
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Vaccination
Vaccines
Communicable Diseases
Immune System
Appointments and Schedules
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Pharmacology (medical)

Cite this

Vaccination in the elderly : What can be recommended? / Lang, Pierre Olivier; Aspinall, Richard.

In: Drugs and Aging, Vol. 31, No. 8, 2014, p. 581-599.

Research output: Contribution to journalReview article

Lang, Pierre Olivier ; Aspinall, Richard. / Vaccination in the elderly : What can be recommended?. In: Drugs and Aging. 2014 ; Vol. 31, No. 8. pp. 581-599.
@article{c3ea8d7a4fef4589a14d6e12c78c9641,
title = "Vaccination in the elderly: What can be recommended?",
abstract = "The age-associated increased susceptibility to infectious disease would suggest that vaccination should be a route to promote healthy aging and keep our seniors autonomous and independent. While vaccination represents a cost-effective and efficient strategy at community level, the ability of the immune system to mount a protective immune response is still unpredictable at the level of the individual. Thus, at a similar age, some individuals, including the elderly, might still be 'good' responders while some other, even younger, would definitely fail to mount a protective response. In this review, the current burden of vaccine-preventable diseases in the aging and aged population will be detailed with the aim to identify the ideal vaccine candidates over the age of 50 years. This article will conclude with potential strategies to reduce, as best as possible, this burden and the imperative need to overcome barriers in extending current vaccine coverage towards to a lifelong vaccine schedule.",
author = "Lang, {Pierre Olivier} and Richard Aspinall",
year = "2014",
doi = "10.1007/s40266-014-0193-1",
language = "English",
volume = "31",
pages = "581--599",
journal = "Drugs and Aging",
issn = "1170-229X",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Vaccination in the elderly

T2 - What can be recommended?

AU - Lang, Pierre Olivier

AU - Aspinall, Richard

PY - 2014

Y1 - 2014

N2 - The age-associated increased susceptibility to infectious disease would suggest that vaccination should be a route to promote healthy aging and keep our seniors autonomous and independent. While vaccination represents a cost-effective and efficient strategy at community level, the ability of the immune system to mount a protective immune response is still unpredictable at the level of the individual. Thus, at a similar age, some individuals, including the elderly, might still be 'good' responders while some other, even younger, would definitely fail to mount a protective response. In this review, the current burden of vaccine-preventable diseases in the aging and aged population will be detailed with the aim to identify the ideal vaccine candidates over the age of 50 years. This article will conclude with potential strategies to reduce, as best as possible, this burden and the imperative need to overcome barriers in extending current vaccine coverage towards to a lifelong vaccine schedule.

AB - The age-associated increased susceptibility to infectious disease would suggest that vaccination should be a route to promote healthy aging and keep our seniors autonomous and independent. While vaccination represents a cost-effective and efficient strategy at community level, the ability of the immune system to mount a protective immune response is still unpredictable at the level of the individual. Thus, at a similar age, some individuals, including the elderly, might still be 'good' responders while some other, even younger, would definitely fail to mount a protective response. In this review, the current burden of vaccine-preventable diseases in the aging and aged population will be detailed with the aim to identify the ideal vaccine candidates over the age of 50 years. This article will conclude with potential strategies to reduce, as best as possible, this burden and the imperative need to overcome barriers in extending current vaccine coverage towards to a lifelong vaccine schedule.

UR - http://www.scopus.com/inward/record.url?scp=84904541204&partnerID=8YFLogxK

U2 - 10.1007/s40266-014-0193-1

DO - 10.1007/s40266-014-0193-1

M3 - Review article

VL - 31

SP - 581

EP - 599

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 8

ER -